Rafferty Asset Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$221,000
-16.0%
8,637
-22.0%
0.00%0.0%
Q2 2022$263,000
+21.8%
11,071
+1.4%
0.00%
+100.0%
Q4 2021$216,000
-18.2%
10,913
+7.9%
0.00%
-66.7%
Q4 2020$264,000
+28.8%
10,110
-17.0%
0.00%0.0%
Q2 2020$205,000
-28.1%
12,185
-52.3%
0.00%
-40.0%
Q2 2019$285,000
-50.3%
25,568
-47.6%
0.01%
-44.4%
Q1 2019$573,000
-41.2%
48,805
-17.6%
0.01%
-35.7%
Q1 2018$974,00059,2010.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders